Sponsor:
CRISPR Therapeutics
Code:
NCT06492304
Conditions
T Cell Lymphoma
B Cell Lymphoma
Acute Myeloid Leukemia
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
CTX131
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations